New research indicates that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who halt conventional lifestyle plans.
Research printed in a major health publication demonstrates that while overweight people often shed a large proportion of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"People buying such drugs must be cognizant of the risk of rapid weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of regain means a return to pre-treatment mass in about one and a half years.
Comparing Therapies
The research, which reviewed dozens of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.
Scientists emphasize that people who lose weight through dieting usually have a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Nutrition scientists propose the mechanism of the jabs accounts for the amplified regain.
These medications imitate a natural hormone called GLP-1, which helps regulate hunger.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the body to produce less of its own natural hormone, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication means appetite is uncontrolled, making binge eating far more likely."
A Chronic Issue?
The NHS advise the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the therapy might need to be long-term.
This view is supported by pharmaceutical companies, who state that the findings "underscore the chronic nature of obesity," similar to managing diseases like diabetes.
User Testimonies
Individuals who have stopped the medication report a powerful resurgence of hunger.
"It was like something that goes on and I was suddenly extremely hungry," said one woman.
The struggle is compounded if patients have not established permanent dietary or behavioural changes during treatment.
Widespread Adoption
Survey data suggest that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Use is higher among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a permanent cure and maintained weight loss likely depends on ongoing lifestyle support.
